Genetic Technologies Limi... (GENE)
NASDAQ: GENE
· Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM
Genetic Balance Sheet Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 1.02M | 3.73M | 7.85M | 5.05M | 11.73M | 11.73M | 13.51M | 13.51M | 20.9M | 20.9M | 16.44M |
Short-Term Investments | 18.79K | n/a | 17.44K | n/a | 13.26K | 13.26K | n/a | n/a | 1.86K | 1.86K | n/a |
Long-Term Investments | n/a | -436.24K | 4.24M | 6.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 81.7K | 436.24K | -4.24M | -6.82M | -6.08M | -6.08M | -5.68M | -5.68M | -9.54M | -637.71K | -9.67M |
Receivables | 209.25K | 1.12M | 1.92M | 2.93M | 2.42M | n/a | 2.71M | n/a | 1.07M | n/a | 1.31M |
Inventory | 206.47K | 396.7K | 325.89K | 404.68K | 398.15K | 398.15K | 334.6K | 334.6K | 76.93K | 76.93K | 114.07K |
Other Current Assets | 1.92M | 474.4K | 17.44K | 423.96K | 18.23K | n/a | 308.75K | n/a | 1.86K | n/a | 230.45K |
Total Current Assets | 3.7M | 5.72M | 10.5M | 8.81M | 14.72M | 14.72M | 16.86M | 16.86M | 22.24M | 22.24M | 18.09M |
Property-Plant & Equipment | 264.49K | 429.23K | 599.18K | 784.99K | 953.33K | 953.33K | 498.95K | 498.95K | 637.71K | 637.71K | 755.2K |
Goodwill & Intangibles | 2.14M | 2.22M | 3.64M | 6.03M | 5.13M | 5.13M | 5.18M | 5.18M | 9.64M | n/a | 9.67M |
Total Long-Term Assets | 2.49M | 2.75M | 4.36M | 6.89M | 6.08M | 6.08M | 5.68M | 5.68M | 735.57K | 637.71K | 755.2K |
Total Assets | 6.19M | 8.47M | 14.86M | 15.69M | 20.8M | 20.8M | 22.54M | 22.54M | 22.97M | 22.97M | 18.84M |
Account Payables | 1.46M | 1.92M | 837.95K | 2.47M | 1.15M | 1.15M | 1.44M | 1.44M | 269.67K | 269.67K | 502.75K |
Deferred Revenue | 479.44K | 764.46K | 849.21K | 1.05M | 814.15K | n/a | 800.3K | n/a | 635.00 | n/a | n/a |
Short-Term Debt | 643.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 547.24K | n/a | n/a | n/a | n/a | 2.66M | n/a | 1.34M | n/a | 1.14M | n/a |
Total Current Liabilities | 4.2M | 3.42M | 3.31M | 4.23M | 3.81M | 3.81M | 2.77M | 2.77M | 1.41M | 1.41M | 1.24M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 46.74K |
Other Long-Term Liabilities | 137.72K | 48.06K | 30.44K | 29.96K | 22.5K | n/a | 106.45K | n/a | 8.86K | n/a | 4.81K |
Total Long-Term Liabilities | 160.64K | 232.94K | 381.62K | 432.74K | 558.91K | n/a | 320.1K | n/a | 33.27K | n/a | 121.25K |
Total Liabilities | 4.36M | 3.65M | 3.69M | 4.67M | 4.37M | 3.81M | 3.09M | 2.77M | 1.44M | 1.41M | 1.36M |
Total Debt | 875.19K | 382.32K | 532.85K | 612.39K | 652.53K | n/a | 113.49K | n/a | 204.04K | n/a | 367K |
Common Stock | 163.82M | 161.34M | 161.34M | 155.14M | 155.14M | 155.14M | 155.14M | 155.14M | 153.57M | 153.57M | 147.07M |
Retained Earnings | -166.38M | -160.78M | -156.72M | -155.67M | -150.21M | -150.21M | -146.96M | -146.96M | -143.08M | -143.08M | -139.52M |
Comprehensive Income | 4.39M | 4.25M | 6.54M | 11.56M | 11.5M | n/a | 11.27M | n/a | 11.03M | n/a | 9.93M |
Shareholders Equity | 1.83M | 4.81M | 11.16M | 11.03M | 16.43M | 4.93M | 19.45M | 8.18M | 21.53M | 10.5M | 17.48M |
Total Investments | 18.79K | -436.24K | 17.44K | 6.82M | 13.26K | 13.26K | n/a | n/a | 1.86K | 1.86K | n/a |